Cargando…

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology

BACKGROUND: Alzheimer’s disease (AD), a neurodegenerative disease, is associated with dysfunction of the olfactory and the entorhinal cortex of the brain that control memory and cognitive functions and other daily activities. Pro-inflammatory cytokines, amyloid-β (Aβ), and the cholinergic system pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Reale, Marcella, D’Angelo, Chiara, Costantini, Erica, Di Nicola, Marta, Yarla, Nagnedra Sastry, Kamal, Mohammad Amjad, Salvador, Nieves, Perry, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817902/
https://www.ncbi.nlm.nih.gov/pubmed/29439355
http://dx.doi.org/10.3233/JAD-170999
_version_ 1783300947833782272
author Reale, Marcella
D’Angelo, Chiara
Costantini, Erica
Di Nicola, Marta
Yarla, Nagnedra Sastry
Kamal, Mohammad Amjad
Salvador, Nieves
Perry, George
author_facet Reale, Marcella
D’Angelo, Chiara
Costantini, Erica
Di Nicola, Marta
Yarla, Nagnedra Sastry
Kamal, Mohammad Amjad
Salvador, Nieves
Perry, George
author_sort Reale, Marcella
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD), a neurodegenerative disease, is associated with dysfunction of the olfactory and the entorhinal cortex of the brain that control memory and cognitive functions and other daily activities. Pro-inflammatory cytokines, amyloid-β (Aβ), and the cholinergic system play vital roles in the pathophysiology of AD. However, the role of changes in cholinergic system components, Aβ accumulation, and cytokines in both the olfactory and entorhinal cortex is not known clearly. OBJECTIVE: The present study is aimed to evaluate the changes of cholinergic system components, Aβ accumulation, and cytokines in both the olfactory bulb (OB) and entorhinal cortex (EC) of young and aged APP(SWE)/PS1dE9 transgenic (Tg) mice. METHODS: We have explored the changes of cholinergic system components, Aβ accumulation, and expression profiling of cytokines in the OB and EC of aged APPswe transgenic mice and age-matched wild type mice using quantitative Real-Time PCR assays and immunohistochemistry techniques. RESULTS: In aged Tg mice, a significant increase of expression of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and chemokine MCP1 (p < 0.001, p < 0.001, and p = 0.001, respectively) and a significant reduction of nAChRα4 (p = 0.048) and AChE (p = 0.023) was observed when compared with age-matched wild type mice. Higher levels of AChE and BuChE are expressed in OB and EC of the APP(SWE)/PS1dE9 of Tg mice. Aβ accumulation was observed in OB and EC of the APP(SWE)/PS1dE9 of Tg mice. CONCLUSION: The study demonstrates the expression profiling of pro-inflammatory cytokines and cholinergic markers as well as Aβ accumulation in OB and EC of the APP(SWE)/PS1dE9 Tg mice. Moreover, the study also demonstrated that the APP(SWE)/PS1dE9 Tg mice can be useful as a mouse model to understand the role of pro-inflammatory cytokines and cholinergic markers in pathophysiology of AD.
format Online
Article
Text
id pubmed-5817902
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-58179022018-02-22 Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology Reale, Marcella D’Angelo, Chiara Costantini, Erica Di Nicola, Marta Yarla, Nagnedra Sastry Kamal, Mohammad Amjad Salvador, Nieves Perry, George J Alzheimers Dis Research Article BACKGROUND: Alzheimer’s disease (AD), a neurodegenerative disease, is associated with dysfunction of the olfactory and the entorhinal cortex of the brain that control memory and cognitive functions and other daily activities. Pro-inflammatory cytokines, amyloid-β (Aβ), and the cholinergic system play vital roles in the pathophysiology of AD. However, the role of changes in cholinergic system components, Aβ accumulation, and cytokines in both the olfactory and entorhinal cortex is not known clearly. OBJECTIVE: The present study is aimed to evaluate the changes of cholinergic system components, Aβ accumulation, and cytokines in both the olfactory bulb (OB) and entorhinal cortex (EC) of young and aged APP(SWE)/PS1dE9 transgenic (Tg) mice. METHODS: We have explored the changes of cholinergic system components, Aβ accumulation, and expression profiling of cytokines in the OB and EC of aged APPswe transgenic mice and age-matched wild type mice using quantitative Real-Time PCR assays and immunohistochemistry techniques. RESULTS: In aged Tg mice, a significant increase of expression of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and chemokine MCP1 (p < 0.001, p < 0.001, and p = 0.001, respectively) and a significant reduction of nAChRα4 (p = 0.048) and AChE (p = 0.023) was observed when compared with age-matched wild type mice. Higher levels of AChE and BuChE are expressed in OB and EC of the APP(SWE)/PS1dE9 of Tg mice. Aβ accumulation was observed in OB and EC of the APP(SWE)/PS1dE9 of Tg mice. CONCLUSION: The study demonstrates the expression profiling of pro-inflammatory cytokines and cholinergic markers as well as Aβ accumulation in OB and EC of the APP(SWE)/PS1dE9 Tg mice. Moreover, the study also demonstrated that the APP(SWE)/PS1dE9 Tg mice can be useful as a mouse model to understand the role of pro-inflammatory cytokines and cholinergic markers in pathophysiology of AD. IOS Press 2018-02-06 /pmc/articles/PMC5817902/ /pubmed/29439355 http://dx.doi.org/10.3233/JAD-170999 Text en © 2018 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Reale, Marcella
D’Angelo, Chiara
Costantini, Erica
Di Nicola, Marta
Yarla, Nagnedra Sastry
Kamal, Mohammad Amjad
Salvador, Nieves
Perry, George
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title_full Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title_fullStr Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title_full_unstemmed Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title_short Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
title_sort expression profiling of cytokine, cholinergic markers, and amyloid-β deposition in the app(swe)/ps1de9 mouse model of alzheimer’s disease pathology
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817902/
https://www.ncbi.nlm.nih.gov/pubmed/29439355
http://dx.doi.org/10.3233/JAD-170999
work_keys_str_mv AT realemarcella expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT dangelochiara expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT costantinierica expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT dinicolamarta expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT yarlanagnedrasastry expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT kamalmohammadamjad expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT salvadornieves expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology
AT perrygeorge expressionprofilingofcytokinecholinergicmarkersandamyloidbdepositionintheappsweps1de9mousemodelofalzheimersdiseasepathology